Background {#s0005}
==========

Currently, multiple studies have identified a wide range of neurological deficits associated with COVID-19 [@b0005], reflecting both immune-mediated process involving the development [@b0010] and parenchymal injury [@b0015]. Furthermore, a recent study by Lu and colleagues demonstrated that microstructural changes in the cerebral parenchyma can occur during the recovery phase from COVID-19 [@b0020], indicating that the onset of CNS damage can be asynchronous with systemic manifestations and the typically salient severe respiratory disease. Asynchronous latency within the CNS may also be surmised by hyposmia, an early symptom of SARS-CoV-2 infection, that may denote presymptomatic (i.e. prior to febrile disease or fulminant respiratory symptoms) transcribial neuroinvasion [@b0025]. The latter concept is supported both by imaging findings involving the frontal lobes [@b0020], and hypometabolism along the olfactory pathways as detected by ^18^FDG-PET/CT [@b0030].

Hypothesis {#s0010}
==========

A recent translatomics experiment [@b0035] revealed that SARS-CoV-2 infection perturbed the expression of three genes crucial for neuronal survival in its host cells: (i) the gene encoding the RNA binding polypyrimidine tract binding protein, PTBP1 and (ii) the genes encoding the isoforms ζ and ε of the 14-3-3 protein, YWHAZ and YWHAE correspondingly.

Considering that aberrant expression of either gene may trigger neurodegeneration, the hypothesis presented herein aims to synthesize the contribution of their physiological roles and conversely, their perturbations, in host -- virus interactions and neurodegenerative disease.

The RNA binding polypyrimidine tract binding protein PTBP1, viruses and neurodegeneration {#s0015}
=========================================================================================

PTBP1 knockdown or depletion has recently been shown to induce neurogenesis and reversal of disease phenotypes in idiopathic Parkinson's disease (iPD) [@b0040]. PTB proteins have been shown to interact with several coronaviruses (CoV) by via their recruitment in regulatory complexes [@b0045]. From α physiological view, the PTB/nPTB spliceosomic switch is a master regulator of neuronal fate and maturation [@b0050]; thus, interactions that would lead to aberrant sequestration, as shown in the extranuclear shuttling of PTBP1 during TMEV infection [@b0055], would be reasonably adequate to induce dysregulate a critical neuronal survival pathway.

In addition to PTBP1, YWHAZ and YHWAE (encoding 14-3-3~ε~ and 14-3-3~ζ~ correspondingly) proteins are also potential contributors to neurodegeneration. In a similar fashion to PTBP1, 14-3-3~ε/ζ~ have been shown to regulate neuronal migration and differentiation in murine models [@b0060]. YWHAZ and YWHAE expression has been linked directly to neurodegenerative disease such as Alzheimer's Disease (AD) [@b0065] and iPD [@b0070], indicating that perturbations introduced by SARS-CoV-2 may be critical for both long term and short-term neuronal survival. Interestingly, 14-3-3~ζ~ regulates autophagy-lysosomal trafficking and ER stress response/proteostasis on the epigenetic level (i.e. via the regulation of histone post-translational modifications), furthermore providing a common mechanism between viral infection, neuronal survival and neurodegeneration. Notably, 14-3-3 proteins were shown to mediate phosphorylation dependent shuttling of SARS-CoV's N protein between cellular compartments, indicating that its differential expression during SARS-CoV-2 infection may be indispensable for its lifecycle [@b0075].

Considering that accommodating mutations may enable long term CNS latency within the CNS [@b0080], neurodegeneration and cerebral structural damage in general may represent the combinatory effects of the viral lifecycle and its interaction with host genetics as the substrate. Considering that both PTBP1 and YWHAE/Z are increasingly recognized as SARS-CoV-2′s targets even by conceptually different studies [@b0085], [@b0090], the question arising is what other host factors mitigate or enhance these perturbations ([Fig. 1](#f0005){ref-type="fig"} ).Fig. 1An integrated model of SARS-CoV-2 neuroinvasion and the perturbations introduced to neurons by targeting PTBP1 and YWHAE and YWHAZ.

These observations offer both retrospective and prospective insight into what might be the basis for a renewed understanding of the neuroimmune bases of neurodegenerative disease, with a central role for PTBP1, YHWAE/Z and their role in epigenetics and mRNA surveillance.
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